Br[C:2]1[CH:3]=[N:4][N:5]2[CH:10]=[CH:9][CH:8]=[CH:7][C:6]=12.[C:11]([NH:14][C:15]1[CH:16]=[C:17](B(O)O)[CH:18]=[CH:19][CH:20]=1)(=[O:13])[CH3:12].C([O-])([O-])=O.[K+].[K+].O>C1(C)C=CC=CC=1.CO.CCO.CC(C)([P](C(C)(C)C)([Pd][P](C(C)(C)C)(C(C)(C)C)C(C)(C)C)C(C)(C)C)C>[N:4]1[N:5]2[CH:10]=[CH:9][CH:8]=[CH:7][C:6]2=[C:2]([C:19]2[CH:20]=[C:15]([NH:14][C:11](=[O:13])[CH3:12])[CH:16]=[CH:17][CH:18]=2)[CH:3]=1A mixture of 3-bromo-pyrazolo[1,5-a]pyridine (197 mg, 1 mmol), (3-acetylaminophenyl)boronic acid (179 mg), K2CO3 (6 eq) and bis(tri-t-butylphosphine)palladium (0) (5 mg) in PhMe (1 ml), MeOH (1 ml), EtOH (1 ml), and H2O (1.8 ml) was stirred and heated at 155° C. in the microwave for 30 minutes. The mixture was partitioned between EtOAc/H2O. The layers were separated and the organic layer was dried, filtered and evaporated. The residue was crystallised from MeOH to give the title compound (50 mg). MS: [M+H]+ 252